Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study - Concepedia

Concepedia

Publication | Open Access

Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study

DOI Full Paper Access

22

Citations

20

References

2019

Year

Chien-Ting Liu, Yen‐Hao Chen, Yu‐Chuen Huang, Shih‐Yu Chen, Ming-Yen Tsai

Abstract

ClinicalTrials.gov, NCT03797248. Registered on 5 January 2019.

References

	Year	Citations
Toxicity and response criteria of the Eastern Cooperative Oncology Group Martin M. Oken, Richard H. Creech, Douglass C. Tormey, American Journal of Clinical Oncology Health SciencesMedicineCancer ManagementClinical EndpointPharmacology	1982	11.4K
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials A.-W. Chan, Jennifer Tetzlaff, Peter C Gøtzsche, BMJ Spirit StatementHealth PolicyClinical Trial ManagementHigh Quality ProtocolsPatient Safety	2013	6.6K
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. Marianne J. Brady, David Cella, Fei Mo, Journal of Clinical Oncology	1997	1.7K
Incidence and Mortality and Epidemiology of Breast Cancer in the World Mahshid Ghoncheh, Zahra Pournamdar, Hamid Salehiniya Asian Pacific Journal of Cancer Prevention EpidemiologyPreventive MedicineCancer EpidemiologyBreast OncologyCancer Risk	2016	1.1K
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer Hyman B. Muss, Donald A. Berry, Constance Cirrincione, New England Journal of Medicine	2009	556
Therapeutic Applications of Herbal Medicines for Cancer Patients Shu‐Yi Yin, Wen‐Chi Wei, Feng-Yin Jian, Evidence-based Complementary and Alternative Medicine OncologyMedicineHerbal MedicineNatural RemediesImmunology	2013	381
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial John R. Mackey, Miguel Martín, Tadeusz Pieńkowski, The Lancet Oncology Node-positive Breast CancerBreast OncologyOncologyAdjuvant DocetaxelBcirg 001	2012	221
Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: A population‐based study Yuan‐Wen Lee, Ta‐Liang Chen, Yu‐Ru V. Shih, Cancer	2014	132
Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework Darius Lakdawalla, Jason Shafrin, Ningqi Hou, Value in Health Empirical EvidencePrognostic EvaluationReal-world EffectivenessMedicineCancer Management	2017	84
Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study Yi-Ting Kuo, Tung‐Ti Chang, Chih‐Hsin Muo, Integrative Cancer Therapies	2017	79

Page 1